Cartesian Therapeutics
RNAC
RNAC
102 hedge funds and large institutions have $71.9M invested in Cartesian Therapeutics in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 41 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
-4
Holders Change %
-3.77%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
28
Reduced
41
Closed
17
Calls
$188K
Puts
$45K
Net Calls
+$143K
Net Calls Change
-$574K
Top Buyers
| 1 |
ECM
1
Endurant Capital Management
San Mateo,
California
|
$4.25M |
| 2 |
2
Renaissance Technologies
New York
|
$1.83M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$1.09M |
| 4 |
EAM
4
Erste Asset Management
Vienna,
Austria
|
$2.5M |
| 5 |
5
Millennium Management
New York
|
$2.26M |
